A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations

Clinical trial NCT06959888 · COMPLETED

Trial details

NCT number: NCT06959888
Sponsor: Aligos Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Study

Start date: 2025-03-25
Primary completion: 2025-05-08
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.